762283-05-6Relevant articles and documents
Bis(aminopyrrolidine)-derived ureas (APUs) as potent MCH1 receptor antagonists
Grey, Jonathan,Dyck, Brian,Rowbottom, Martin W.,Tamiya, Junko,Vickers, Troy D.,Zhang, Mingzhu,Zhao, Liren,Heise, Christopher E.,Schwarz, David,Saunders, John,Goodfellow, Val S.
, p. 999 - 1004 (2007/10/03)
Ureas derived from two substituted 3-aminopyrrolidine subunits were prepared as constrained analogs of a linear lead compound and tested as antagonists of the MCH1 receptor. The series was optimized for substitution and stereochemistry to generate a functional antagonist with a Ki of 3.3 nM and IC50 of 12 nM (GTPγS).
MELANIN-CONCENTRATING HORMONE RECEPTOR ANTAGONISTS AND COMPOSITIONS AND METHODS RELATED THERETO
-
Page 114, (2010/02/08)
Melanin-concentrating hormone (MCH) receptor antagonists are disclosed having utility for the treatment of MCH receptor-based disorders such as obesity. The compounds of this invention have the following structure: including stereoisomers, prodrugs, and pharmaceutically acceptable salts thereof, wherein m, n, X, R1, R2, R3, R4, and R5 are as defined herein. Also disclosed are compositions containing a compound of this invention, as well as methods relating to the use thereof.